These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30515808)

  • 1. Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.
    Sujan AC; Öberg AS; Quinn PD; D'Onofrio BM
    J Child Psychol Psychiatry; 2019 Apr; 60(4):356-376. PubMed ID: 30515808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
    Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
    JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
    Morales DR; Slattery J; Evans S; Kurz X
    BMC Med; 2018 Jan; 16(1):6. PubMed ID: 29332605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children.
    Heuvelman H; Davies NM; Ben-Shlomo Y; Emond A; Evans J; Gunnell D; Liebling R; Morris R; Payne R; Storey C; Viner M; Rai D
    Health Technol Assess; 2023 Sep; 27(15):1-83. PubMed ID: 37842916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternal Depression as a Risk Factor for Neurodevelopmental Disorders in Offspring: Implications for Maternal Depression and Its Treatment During Pregnancy.
    Andrade C
    J Clin Psychiatry; 2020 Dec; 81(6):. PubMed ID: 33264818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes as Unmeasured and Unknown Confounds in Studies of Neurodevelopmental Outcomes After Antidepressant Prescription During Pregnancy.
    Andrade C
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32459403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Antidepressants be Avoided in Pregnancy?
    Besag FMC; Vasey MJ
    Drug Saf; 2023 Jan; 46(1):1-17. PubMed ID: 36538238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.
    Clements CC; Castro VM; Blumenthal SR; Rosenfield HR; Murphy SN; Fava M; Erb JL; Churchill SE; Kaimal AJ; Doyle AE; Robinson EB; Smoller JW; Kohane IS; Perlis RH
    Mol Psychiatry; 2015 Jun; 20(6):727-34. PubMed ID: 25155880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
    Man KKC; Chan EW; Ip P; Coghill D; Simonoff E; Chan PKL; Lau WCY; Schuemie MJ; Sturkenboom MCJM; Wong ICK
    BMJ; 2017 May; 357():j2350. PubMed ID: 28566274
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?
    Cesta CE; Öberg AS; Ibrahimson A; Yusuf I; Larsson H; Almqvist C; D'Onofrio BM; Bulik CM; Fernández de la Cruz L; Mataix-Cols D; Landén M; Rosenqvist MA
    Psychol Med; 2020 Mar; 50(4):616-624. PubMed ID: 30857571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.
    Castro VM; Kong SW; Clements CC; Brady R; Kaimal AJ; Doyle AE; Robinson EB; Churchill SE; Kohane IS; Perlis RH
    Transl Psychiatry; 2016 Jan; 6(1):e708. PubMed ID: 26731445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
    Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
    JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review.
    Araujo JSA; Delgado IF; Paumgartten FJR
    Cad Saude Publica; 2020; 36(2):e00026619. PubMed ID: 32022173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.
    Tadesse AW; Dachew BA; Ayano G; Betts K; Alati R
    J Psychiatr Res; 2024 Mar; 171():142-151. PubMed ID: 38281464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational exposure to benzodiazepines or z-hypnotics and neurodevelopmental disorders in offspring: Systematic review and meta-analysis.
    Andrade C; Varadharajan N; Bascarane S; Menon V
    Acta Psychiatr Scand; 2024 Aug; 150(2):65-77. PubMed ID: 38751163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia: The Norwegian Mother, Father and Child Cohort Study (MoBa).
    Havdahl A; Wootton RE; Leppert B; Riglin L; Ask H; Tesli M; Bugge Askeland R; Hannigan LJ; Corfield E; Øyen AS; Andreassen OA; Tilling K; Davey Smith G; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2022 Aug; 79(8):799-810. PubMed ID: 35793100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant use during pregnancy and the risk of attention-deficit/hyperactivity disorder in the children: a meta-analysis of cohort studies.
    Jiang HY; Peng CT; Zhang X; Ruan B
    BJOG; 2018 Aug; 125(9):1077-1084. PubMed ID: 29243299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium.
    Kurth L; O'Shea TM; Burd I; Dunlop AL; Croen L; Wilkening G; Hsu TJ; Ehrhardt S; Palanisamy A; McGrath M; Churchill ML; Weinberger D; Grados M; Dabelea D
    J Neurodev Disord; 2024 May; 16(1):26. PubMed ID: 38796448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: Studies of prenatal antidepressant exposures: what can you recommend? A reflection on Sujan et al. (2019).
    Talati A; Weissman MM
    J Child Psychol Psychiatry; 2019 Apr; 60(4):377-379. PubMed ID: 30919484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.